<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04310501</url>
  </required_header>
  <id_info>
    <org_study_id>RESCOMUOI82476</org_study_id>
    <nct_id>NCT04310501</nct_id>
  </id_info>
  <brief_title>Interactive E-health Database for the Identification of Potential Interactions Among Drugs Prescribed to CKD Patient</brief_title>
  <official_title>Development of an Interactive E-health Database Aimed to Identify Potential Interactions Among Drugs Prescribed to Chronic Kidney Disease (CKD) Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ioannina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ioannina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current project is the development and implementation of an e-health database
      of drug interactions (drug-drug, drug-food, drug-alcohol and drug-herbal products
      interaction) to CKD patients in order to achieve a holistic approach to patient care and
      personalized medicine. The study will be conducted in the University of Ioannina (cooperation
      between the Department of Nephrology and the Laboratory of Physiology). Data will be
      collected form 150 CKD patients (Stages 1-5 pre-dialysis, undergoing dialysis, kidney
      transplantation). Sixty patients will be selected for the pilot study which will include
      blood and urine tests and specific polymorphism analysis (pharmacogenetic tests). Pilot
      implementation of the e-health database will be undertaken by health professionals of the
      Department of Nephrology (University Hospital of Ioannina) to test the system in realistic
      setting (usability, efficiency and efficacy) in order to make the necessary changes prior to
      full scale deployment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>E-health database</measure>
    <time_frame>1-12 months until completion of patients recruitment</time_frame>
    <description>E-health database of drug interactions (drug-drug, drug-food, drug-alcohol and drug-herbal products interaction) to CKD patients in order to achieve a holistic approach to patient care and personalized medicine.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>CKD Patients</arm_group_label>
    <description>Patients (n=150) with CKD (Stages 1-5 pre-dialysis, undergoing dialysis, kidney transplantation) who fulfil the inclusion criteria from the Nephrology Dept and Renal Transplant Unit of the University Hospital of Ioannina.
Sixty patients will be selected for the pilot study which will include blood and urine tests and specific polymorphism analysis (pharmacogenetic tests)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        150 patients with Chronic Kidney Disease (stages 1-5 pre-dialysis, kidney transplantation)
        from the Nephrology Department of University Hospital of Ioannina
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 years

          -  CKD diagnosis according to KDOQI Guidelines

          -  absence of active malignancy

          -  absence of decompensated heart failure New York Heart Association (NYHA) IV

          -  absence of liver cirrhosis

          -  patient's consent

        Exclusion Criteria:

          -  Age&lt;18 years

          -  active malignancy

          -  decompensated heart failure NYHA IV

          -  liver cirrhosis

          -  patient's refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evangelia Ntounousi, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ioannina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evangelia Ntounousi, PHD</last_name>
    <phone>+302651099653</phone>
    <email>evangeldou@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Ioannina</name>
      <address>
        <city>Ioánnina</city>
        <zip>45110</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Andersson ML, Böttiger Y, Lindh JD, Wettermark B, Eiermann B. Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. Eur J Clin Pharmacol. 2013 Mar;69(3):565-71. doi: 10.1007/s00228-012-1338-y. Epub 2012 Jul 1.</citation>
    <PMID>22752671</PMID>
  </reference>
  <reference>
    <citation>Classen DC, Phansalkar S, Bates DW. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches. J Patient Saf. 2011 Jun;7(2):61-5. doi: 10.1097/PTS.0b013e31821d6f6e. Review.</citation>
    <PMID>21577077</PMID>
  </reference>
  <reference>
    <citation>Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007 Nov 7;298(17):2038-47.</citation>
    <PMID>17986697</PMID>
  </reference>
  <reference>
    <citation>Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007 Jul 14;370(9582):185-191. doi: 10.1016/S0140-6736(07)61092-7. Review.</citation>
    <PMID>17630042</PMID>
  </reference>
  <reference>
    <citation>Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet. 2000 Nov 11;356(9242):1667-71. Review.</citation>
    <PMID>11089838</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>March 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ioannina</investigator_affiliation>
    <investigator_full_name>Evangelia Ntounousi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Drug Interactions</keyword>
  <keyword>Polymorphism, Genetic</keyword>
  <keyword>Pharmacogenetics</keyword>
  <keyword>Databases, Pharmaceutical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

